The future of diagnostics post-COVID

Featured Presenter; Max Kunz, CEO of Sales,
Marketing and Strategy, Volpi

THURSDAY • 10:30AM EST/2:30PM GMT • MAY 20, 2021

Covid has certainly changed the diagnostics industry landscape.

The question is how much and for how long? How many of the changes are unique to Covid and will disappear in a post-Covid world? How many are here to stay? We don’t have all the answers, but we have collected many of the key issues the industry is thinking about both long and short-term.

Join us on Thursday, May 20th for a webinar on the future of Diagnostics post-COVID with Volpi CEO Max Kunz.

We'll discuss issues including:
Miniaturization of PCR testing instruments
  • Is this a winning strategy? Or are instrument manufacturers fighting 'the last war?'
A changed diagnostics regulatory landscape
Rate of M & A – rising or slowing?
The rise of telehealth with in-home testing options
And much more.

Register here for an informative session on Thursday, May 20 at 10:30 AM EST/2:30 PM GMT.

Your Host

Get it right the first time.

The world’s leading instrument brands know the importance of a proper optical design transfer process, and they rely on more than internal expertise to make their designs a manufacturing reality. Success requires deep optoelectronic expertise, a proven design transfer process and a relentless focus on quality.

Avoid the pitfalls.

Don’t be plagued by the common pitfalls of the design transfer process. Learn how you can ensure a seamless transfer to manufacturing, improving both time to market, and your bottom line with this free guide from Volpi, a leading provider of optoelectronics for many of the world's most trusted life sciences and diagnostics instrument manufacturers.
Ken Dec

Max Kunz,
CEO of Sales,
Marketing and Strategy,
Volpi

Register now for:
WEBINAR: The future of diagnostics post-COVID

THURSDAY • 10:30AM EST/2:30PM GMT • MAY 20, 2021